BIOVIA

BIOVIA is a scientific software brand headquartered in the United States and operating through representation in Europe and Asia. Its products support research, development, laboratory operations, manufacturing process understanding, regulatory compliance, and quality activities across chemistry, materials science, biotechnology, pharmaceuticals, consumer packaged goods, aerospace, energy, and chemical manufacturing. The business originated as Accelrys, a software company created in 2001 as a wholly owned subsidiary of Pharmacopeia, Inc. Accelrys was assembled from a group of scientific-computing businesses, including Molecular Simulations, Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group, and Synomics. Molecular Simulations itself reflected earlier combinations involving Biodesign, Cambridge Molecular Design, Polygen, Biocad, and Biosym Technologies. This heritage gave the company a broad portfolio spanning molecular modeling, chemistry databases, bioinformatics, scientific workflow automation, and laboratory information management. In late 2003, Pharmacopeia separated its drug-discovery and software activities. Pharmacopeia retained the drug-discovery business in Princeton, New Jersey, while the software operation moved to San Diego, California. Accelrys subsequently expanded through product development and acquisitions. In 2004 it acquired SciTegic, adding Pipeline Pilot, a platform for connecting disparate research data and automating scientific analytics. From 2004 through 2010, the company also managed a nanotechnology consortium focused on software tools for rational nanodesign. The 2010 combination with Symyx Technologies strengthened its materials-science and simulation capabilities. Further acquisitions broadened Accelrys from computational research into electronic laboratory notebooks, pharmaceutical and medical-device development, process analytics, manufacturing data, environmental health and safety, and cloud-based collaboration. These transactions included Contur Software in 2011, VelQuest, HEOS, Aegis Analytical, Vialis, and ChemSW between 2012 and 2013. The resulting portfolio linked modeling and simulation with laboratory execution, data management, process development, quality, and production operations. Dassault Systèmes announced its acquisition of Accelrys in January 2014. Following completion of the all-cash transaction in April 2014, Accelrys became a wholly owned subsidiary of the French industrial-software group and was renamed BIOVIA. The BIOVIA identity positioned the business within Dassault Systèmes' broader 3DEXPERIENCE ecosystem while preserving its focus on scientific and engineering applications. Its portfolio includes Materials Studio for materials modeling, Discovery Studio for life-science modeling, Pipeline Pilot for scientific data workflows, electronic laboratory notebooks, process-management tools, chemical information systems, and manufacturing and quality-data applications. BIOVIA's role is primarily enterprise and professional rather than consumer-facing. Its software is intended to help researchers and process teams organize complex scientific information, perform simulation and analysis, manage experiments, connect laboratory and production data, and make development and quality decisions in regulated environments. The brand also distributes commercial versions of certain academically originated scientific programs, including CHARMM and MODELLER. No separate public-company financial reporting, stock ticker, or independently listed status is identified for BIOVIA because it operates as part of Dassault Systèmes.

BIOVIA developed from the scientific-software company Accelrys, which was formed in 2001 as a wholly owned subsidiary of Pharmacopeia, Inc. The formation combined five businesses: Molecular Simulations, Synopsys Scientific Systems, Oxford Molecular, the Genetics Computer Group, and Synomics. Molecular Simulations had in turn been built through earlier combinations involving Biodesign, Cambridge Molecular Design, Polygen, Biocad, and Biosym Technologies. This lineage gave Accelrys a starting portfolio covering molecular simulation, computational chemistry, bioinformatics, chemical structures, and scientific data management. A corporate separation at Pharmacopeia in late 2003 divided the drug-discovery operation from the software business. Pharmacopeia retained its drug-discovery identity and Princeton location, while the software business moved to San Diego. Accelrys then pursued a strategy of combining internal scientific software with targeted acquisitions. In 2004, it acquired SciTegic, whose Pipeline Pilot platform became a central tool for connecting heterogeneous scientific data, constructing analytical workflows, and automating research processes. Between 2004 and 2010, Accelrys managed a nanotechnology consortium that produced software tools intended to support rational nanodesign. The 2010 merger with Symyx Technologies expanded the business in materials modeling and simulation. Accelrys continued broadening beyond computational research with the 2011 acquisition of Contur Software, an electronic laboratory notebook provider. In 2012, it acquired VelQuest, whose software served pharmaceutical and medical-device development contexts; purchased HEOS from Scynexis, adding a cloud-oriented system for project, assay, chemical-registration, analytics, and pharmacokinetic information; and acquired Aegis Analytical for approximately $30 million in cash. Aegis's Discoverant platform was designed to aggregate and contextualize process-development, manufacturing, and quality data for regulated biotechnology and pharmaceutical customers. In 2013, Accelrys acquired Vialis AG, a Swiss biosciences systems integrator, for approximately $5 million in cash, and acquired ChemSW, an environmental health and safety compliance provider. These additions reinforced a portfolio that connected scientific modeling and data management with laboratory execution, process development, manufacturing, regulatory compliance, and quality-by-design programs. On January 30, 2014, Dassault Systèmes announced an all-cash tender offer for Accelrys. The proposed consideration was $12.50 per share, representing an announced fully diluted equity value of about $750 million. Following completion of the acquisition in April 2014, Accelrys became a wholly owned Dassault Systèmes subsidiary and was renamed BIOVIA. Under the BIOVIA identity, the business is positioned as a provider of scientific applications within Dassault Systèmes' wider industrial-software portfolio. Its offerings span the BIOVIA Enterprise Platform, Pipeline Pilot, chemical drawing and database tools, electronic laboratory notebooks, process-management and compliance applications, Discoverant, laboratory execution systems, Materials Studio, Discovery Studio, and commercial versions of CHARMM and MODELLER. The portfolio serves research and development teams as well as manufacturing, quality, and compliance functions. BIOVIA is therefore best understood as an enterprise scientific-software brand rather than an industrial-machinery manufacturer or a consumer product brand.

1. 2014Dassault Systèmes acquisition and BIOVIA rebrand

   Dassault Systèmes acquired Accelrys, which subsequently became the BIOVIA brand.

   Source
2. 2013Vialis and ChemSW acquisitions

   Accelrys expanded its biosciences integration and environmental health and safety compliance activities through acquisitions of Vialis and ChemSW.

   Source
3. 2012Expansion into process and manufacturing analytics

   The acquisitions of VelQuest, HEOS, and Aegis Analytical broadened the portfolio into pharmaceutical development, cloud collaboration, and process and quality data analysis.

   Source
4. 2010Symyx Technologies merger

   Accelrys combined with Symyx Technologies, strengthening its materials-science software capabilities.

   Source
5. 2004SciTegic acquisition

   Accelrys acquired SciTegic and added Pipeline Pilot to its scientific workflow portfolio.

   Source
6. 2003Pharmacopeia separates its software and drug-discovery activities

   The software business separated from Pharmacopeia's drug-discovery operation and moved to San Diego, California.

   Source
7. 2001Accelrys is formed

   Accelrys was established as a wholly owned Pharmacopeia subsidiary through the combination of five scientific-software businesses.

   Source

Enterprise scientific software for connecting research data, computational modeling, laboratory execution, process development, manufacturing, and quality operations across regulated and research-intensive industries.

• BIOVIA Enterprise PlatformScientific informatics platform

  An enterprise-oriented scientific architecture designed to connect data management, informatics, laboratory management, modeling and simulation, and workflow automation. It is intended to provide a common foundation for scientific information and processes across research and development organizations.

• Pipeline PilotScientific workflow and data analytics2004

  A workflow environment that helps researchers access disparate scientific data, automate analytical procedures, and explore, visualize, and report results. It is designed to reduce the separation between data repositories and computational research activities.

• Materials StudioMaterials modeling and simulation

  A suite of computational tools for materials science research. It supports modeling and simulation activities used to investigate materials behavior, properties, and molecular or atomistic structures.

• Discovery StudioLife-science modeling and simulation

  A suite of modeling and simulation applications for life-science research, including computational approaches used in biological and pharmaceutical investigation.

• DiscoverantProcess and quality analytics

  A validation-ready system for accessing, aggregating, contextualizing, analyzing, and reporting process-development, manufacturing, and quality data. It is aimed particularly at regulated biotechnology and pharmaceutical environments and supports process understanding and quality improvement.

• BIOVIA Notebook and electronic laboratory notebooksLaboratory informatics2011

  Electronic laboratory notebook products used to record, organize, share, and manage experimental information. The portfolio reflects Accelrys' expansion into structured laboratory operations and collaborative research documentation.

• Process Management and Compliance SuiteProcess development and compliance

  A group of applications supporting analytical, formulation, process and bioprocess development, stability work, materials testing, release testing, quality control, and commercial production activities.

• Chemical information toolsChemical drawing and databases

  The historical portfolio included ISIS/Draw, ISIS/Base, ISIS/Host, Accelrys Draw, Accelrys Direct, and the Available Chemicals Directory. These tools supported chemical structure drawing, substance registration, database management, Oracle-based chemical information, and supplier-catalog searching.

• CHARMMMolecular mechanics and simulation

  A commercially available molecular simulation program originating in academic research at Harvard and used for computational studies of molecular systems.

• MODELLERComputational structural biology

  A commercially available program for computational modeling in structural biology, included among the academically originated software products distributed commercially through the Accelrys/BIOVIA portfolio.

• 2014Accept Dassault Systèmes' acquisitionM&A

  Accelrys had assembled a broad scientific software portfolio through mergers and acquisitions, while Dassault Systèmes sought to expand its industrial software capabilities into chemistry, materials, life sciences, and scientific informatics.

  What changed. Dassault Systèmes announced and completed an all-cash acquisition of Accelrys. The consideration announced was $12.50 per share, with an approximate fully diluted equity value of $750 million. Accelrys was subsequently renamed BIOVIA.

  Aftermath. BIOVIA became a wholly owned Dassault Systèmes subsidiary and continued as the group's scientific software brand.

  Announced fully diluted equity value. $750 million (2014 acquisition announcement)

  Source

• 2014Dassault Systèmes announces acquisition of Accelrys

  Dassault Systèmes announced an all-cash tender offer for Accelrys at $12.50 per share, with an announced fully diluted equity value of approximately $750 million.

  M&A
  Source
• 2014Accelrys is renamed BIOVIA

  After Dassault Systèmes completed the acquisition, Accelrys became a wholly owned subsidiary and adopted the BIOVIA name.

  M&ALeadership change
  Source
• 2013Accelrys acquires Vialis

  Accelrys acquired Swiss biosciences systems integrator Vialis AG, adding implementation and integration capabilities in life-science information systems.

  M&A
  Source
• 2013Accelrys acquires ChemSW

  The acquisition of ChemSW expanded Accelrys' environmental health and safety compliance software activities.

  M&ARegulation
  Source
• 2012Accelrys acquires VelQuest

  The acquisition of VelQuest added software associated with pharmaceutical and medical-device development and compliance workflows.

  M&A
  Source
• 2012Accelrys purchases HEOS from Scynexis

  Accelrys acquired the HEOS cloud-based system, which supported project information, biological assay results, analytics, chemical registration, and pharmacokinetic data.

  M&A
  Source
• 2012Accelrys acquires Aegis Analytical

  The acquisition brought Aegis Analytical's Discoverant system into Accelrys, strengthening the connection between laboratory process development, manufacturing data, quality analysis, and regulated production.

  M&A
  Source
• 2011Accelrys expands into electronic laboratory notebooks

  Accelrys acquired Contur Software, an electronic laboratory notebook company, extending its laboratory informatics offering.

  M&AProduct generation
  Source
• 2010Accelrys and Symyx Technologies combine

  The combination with Symyx Technologies broadened Accelrys' materials-science, modeling, and simulation capabilities.

  M&A
  Source
• 2004Accelrys acquires SciTegic and adds Pipeline Pilot

  Accelrys acquired SciTegic, bringing Pipeline Pilot into its portfolio and expanding its capabilities in scientific data integration, workflow automation, and research analytics.

  M&AProduct launch
  Source

1. BIOVIA